first_img Are you on the lookout for UK growth stocks?If so, get this FREE no-strings report now.While it’s available: you’ll discover what we think is a top growth stock for the decade ahead.And the performance of this company really is stunning.In 2019, it returned £150million to shareholders through buybacks and dividends.We believe its financial position is about as solid as anything we’ve seen.Since 2016, annual revenues increased 31%In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259Operating cash flow is up 47%. (Even its operating margins are rising every year!)Quite simply, we believe it’s a fantastic Foolish growth pick.What’s more, it deserves your attention today.So please don’t wait another moment. Our 6 ‘Best Buys Now’ Shares Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Softcat. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. FREE REPORT: Why this £5 stock could be set to surge Softcat’s share price soars as forecasts are upgraded! The FTSE 250 is rising towards new record highs in Wednesday trading. Britain’s second-tier UK share index is almost 1% higher on the day and just 150 points off recent all-time highs around 22,775 points. The Softcat (LSE: SCT) share price is one of the index’s strongest risers too in mid-week business.At £19.10 per share, the Softcat share price is up 6% from Tuesday’s close. The FTSE 250 tech share is also a whisker off its own record close of £19.69 set earlier this month. This is thanks to a positive reception to the company’s latest financials.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…Softcat to beat expectationsIn a trading update for its third quarter Softcat said that it “continued to trade well” following an “exceptional” first half of the financial year ending in July.The IT giant “delivered further double-digit year-on-year growth in revenue, gross profit and operating profit,” it said, adding that this reflected “[a] performance that was generally more broad-based than that seen in the first half.”Softcat saw run-rate transaction volumes strengthen during the third quarter. Meanwhile cash collections and conversion had remained “good” in the three-month period.As a consequence the FTSE 250 firm expects results for the full financial year to beat expectations.A bright outlookLooking beyond the current year, Softcat said that “cost savings related to Covid are expected to reverse” in fiscal 2022. It said that customer visits and attending internal events will again become possible as pandemic-related lockdowns are rolled back.Softcat also noted that it had enjoyed some of the biggest deals in its history during the first half of financial 2021. And “significant elements” of these “were one-off in nature.” These business wins, allied with those cost savings, were expected to contribute £12m to this year’s results.The IT firm therefore expects earnings before interest and tax (EBIT) in financial 2022 to be “broadly in line” with that reported in the current period following today’s announced upgrades. It added too that “we remain confident of the road ahead and expect to see further growth” beyond next year.Why I’d buy this UK shareIt’s clear that Softcat will find it difficult to replicate this year’s exceptional results. Covid-19 lockdowns and the subsequent spike in homeworking helped sales to explode across many UK tech stocks since March 2020.But I’m confident that Softcat will enjoy still strong and sustained revenues and profits growth beyond the short term. Companies across the globe are switching to more flexible working models following the public health crisis. This provides firms like Softcat — a rising star in the field of IT infrastructure — with plenty of business to win in the future.I’m aware, though, that this UK share trades on a forward price-to-earnings (P/E) ratio of 42 times. Elevated valuations like that can lead to sharp share price corrections if news flow surrounding the firm starts to disappoint. Enter Your Email Addresscenter_img Simply click below to discover how you can take advantage of this. See all posts by Royston Wild I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Image source: Getty Images. Royston Wild | Wednesday, 26th May, 2021 | More on: SCT Get the full details on this £5 stock now – while your report is free.last_img read more

first_imgCopyApartments•Santa María del Mar, Peru Projects Lead Architect: Miguel Gutierrez Stewart Architects: Martin Dulanto Area Area of this architecture project Paquidermo Residential Building / Martin DulantoSave this projectSavePaquidermo Residential Building / Martin Dulanto Area:  1232 m² Year Completion year of this architecture project Photographs Save this picture!© Juan Solano Ojasi y Renzo Rebagliati+ 28Curated by Clara Ott Share ShareFacebookTwitterPinterestWhatsappMailOr Clipboard Client:PrivadoEngineering:Jorge AvendañoCity:Santa María del MarCountry:PeruMore SpecsLess SpecsSave this picture!© Juan Solano Ojasi y Renzo RebagliatiRecommended ProductsWindowsLibartVertical Retracting Doors & WindowsWoodBruagBalcony BalustradesWindowspanoramah!®ah!38 – FlexibilityWindowsAir-LuxSliding Window – CurvedText description provided by the architects. The taking of part of this project, consists of 3 independent departments for members of the same family, arises the need of the client to have privacy with respect to his neighbors.Save this picture!© Juan Solano Ojasi y Renzo RebagliatiSave this picture!© Juan Solano Ojasi y Renzo RebagliatiThe land where he building is located has 2 lots, although one of them (the posterior) looks directly to the sea, the other one, the main one, faces to a multifamily building of 9 floors of height, whose windows look directly to the Pachyderm Building, generating the sensation of being directly exposed.Save this picture!© Juan Solano Ojasi y Renzo RebagliatiTo solve his problem, 2 measures are taken:On the one hand, the façade which looks at the main entrance is considered fairly closed, with small windows which are enough to allow proper ventilation and natural lighting of the environment’s that are facing this façade without being exposed to the exterior.Save this picture!© Juan Solano Ojasi y Renzo RebagliatiOn the other hand, the project is recessed from the northern boundary, generating a passage between the building and the neighbor’s house. This passage fulfills the function of a patio through which all the environments ventilate and illuminate naturally.Save this picture!© Juan Solano Ojasi y Renzo RebagliatiThe building presents a transition between the 3 façades, which goes from the closest in the east as it faces the neighbors, evolving to a semi-open in the lateral façade, to finally opening almost entirely to the west front and thus be able to appreciate the immensity of the Pacific Ocean.Save this picture!© Juan Solano Ojasi y Renzo RebagliatiProject gallerySee allShow lessPress Box / SET ArchitectsSelected ProjectsAMO Helps to Curate Virgil Abloh Exhibition for the Museum of Contemporary Art ChicagoArchitecture NewsProject locationAddress:Santa María del Mar, PeruLocation to be used only as a reference. It could indicate city/country but not exact address. Share Apartments 2018 Year:  “COPY” Photographs:  Juan Solano Ojasi y Renzo Rebagliati Manufacturers Brands with products used in this architecture project Manufacturers: Otis, Ambienta Perú, Avance Comercial (Pedro Medina), Bluepool, Casa Rosselló, Chavez Constructores, Daniel Muñoz, Mandros, Parking Solutions, Raúl Trujillo, Ángel Cuba CopyAbout this officeMartin DulantoOfficeFollow#TagsProjectsBuilt ProjectsSelected ProjectsResidential ArchitectureHousingApartmentsSanta Maria del MarPeruPublished on June 12, 2019Cite: “Paquidermo Residential Building / Martin Dulanto” [Edificio Paquidermo / Martin Dulanto] 12 Jun 2019. ArchDaily. Accessed 11 Jun 2021. ISSN 0719-8884Browse the CatalogFaucets / SinkshansgroheKitchen SinksGlass3MSun Control Window Film in MarkthalPartitionsSkyfoldIntegrating Operable Walls in a SpaceRetractable StructuresShadeFXRetractable Canopies in Beverly HillsPanels / Prefabricated AssembliesIsland Exterior FabricatorsSpecialty Facade SystemsWoodSculptformTimber Tongue and Groove CladdingSkylightsVELUX CommercialLonglight 5-30° – Modular SkylightsBars / Wire / MeshJakobWebnet – Sports NetSuspension SystemsMetawellAluminum Panels for Ceiling SailsMineral / Organic PaintsKEIMTiO2-free Mineral Paint – Soldalit®-ArteHanging LampsLuminisPendant Lights – HollowcoreHandicap BathroomAamsco Lighting, Inc.Mirror-Lux LED Illuminated MirrorMore products »Save世界上最受欢迎的建筑网站现已推出你的母语版本!想浏览ArchDaily中国吗?是否翻译成中文现有为你所在地区特制的网站?想浏览ArchDaily中国吗?Take me there »✖You’ve started following your first account!Did you know?You’ll now receive updates based on what you follow! Personalize your stream and start following your favorite authors, offices and users.Go to my stream Paquidermo Residential Building / Martin Dulanto “COPY” Peru ShareFacebookTwitterPinterestWhatsappMailOr Clipboard ArchDailylast_img read more

first_imgNew chief executive at SeeAbility Howard Lake | 20 June 2003 | News SeeAbility, formerly known as The Royal School for the Blind, provides a range of accommodation, rehabilitation, day centre and support services that empower blind or partially sighted people with additional disabilities to achieve their full potential and gain maximum independence to live fulfilling lives.Mr Scott-Ralphs said: “SeeAbility has a very good story to tell. My hope is that in the coming years we can tell that story more widely, winning new supporters and, most importantly, reaching more of those who would benefit from our care and support.” David Scott-Ralphs, currently Director of Strategy & Communication at Mencap, is to become SeeAbility’s new Chief Executive.He will succeed Robert Perkins who retires on 11 July 2003 after 13 years at the SeeAbility. Scott-Ralphs takes the lead at SeeAbility as it starts to spread its services for the visually impaired with additional disabilities further across the South of England. Advertisement  28 total views,  1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThiscenter_img AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Tagged with: Management Recruitment / people About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of Researching massive growth in giving.last_img read more

first_img  19 total views,  1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis This year, the judges are offering five tips for online reporting:* Don’t just convert the printed document into digital images (in effect scan the hard copy and put online). It will fail the user from both an accessibility and usability point of view.* Make navigation quick and easy – users are likely to want to ‘dip in and out’ of the report to find answers to specific questions. They are unlikely to read it in its entirety * Make accounts and reports available in HTML and PDF. Ideally two versions of the PDF should be available, one with images/photography and one without. * Ensure the annual report is fully accessible. It should be designed to allow equal access to information and services to all users, including those with visual, hearing, cognitive and motor impairments.* Make the report interactive. For example, links to strategy or results videos, the most recent presentations, charting tools and Excel downloads and links to other stakeholder information can all help to bring the content to life. The competition is open to any registered charity and there is no charge to enter. Tagged with: Awards Finance About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of Researching massive growth in giving.center_img Charities have just one week in which to submit their application for this year’s Charities’ Online Accounts Awards.The Awards are sponsored by CAF and the Institute of Chartered Accountants in England and Wales and celebrate the best online reports and accounts in the sector.Endorsed by senior accountants, and with UK Fundraising as its online media partner, the competition is split into four income categories: below £100,000; between £100k and £500k; between £500k and £2 million; and over £2 million. First, second and third place winners in each category will receive £5,000, £750 and £250 respectively. Advertisement Deadline approaches for entering Charities’ Online Accounts Awards Howard Lake | 10 July 2006 | Newslast_img read more

first_img AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Howard Lake | 10 December 2012 | News  20 total views,  1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis CARDI is a not for profit organisation developed by leaders from the ageing field across Ireland (North and South) including age focused researchers, academics, statutory, voluntary and community sector representatives with support from The Atlantic Philanthropies. It is overseen by a Steering Group and hosted by the Institute of Public Health in Grants up to €20,000 are now available for organisations conducting research into ageing and health in Ireland. The Centre for Ageing Research and Development in Ireland (CARDI) is providing €100,000 for projects which use recently published research data on ageing.As examples of this data, CARDI refers to the 2011 Census in Northern Ireland and the Republic of Ireland and the Irish Longitudinal Study on Ageing.Applications for individual grants range from €5,000 to a maximum of €20,000 available for a single project. Applications are invited from individuals or groups from academic, non-profit and voluntary and community sectors. The deadline for applications is 4 February 2013 and application forms, which are available on the website, can be submitted electronically. Advertisementcenter_img Research grants on ageing in Ireland on offer Tagged with: Funding Ireland About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of Researching massive growth in giving.last_img read more

first_img  573 total views,  1 views today There is only One Gin which funds clean water projects. Help us change lives this #WorldWaterDay with #IWSC gold award winning #OneGoodGin— One Gin (@TheSpiritOfOne) March 22, 2018 Advertisement Tagged with: alcohol corporate Fundraising ideas About Melanie May Melanie May is a journalist and copywriter specialising in writing both for and about the charity and marketing services sectors since 2001. She can be reached via 1897 Quinine Gin supports Malaria No More UK, with at least £5 from every bottle sold donated to the charity to help end malaria. Opihr Oriental Spiced Gin is the Official Gin of the charity Elephant Family, which protects Asian elephants. And of course you’ll need some tonic:We’re part of the fight to eliminate malaria, a devastating disease that kills a child every 2 minutes. In April, every time someone shares a picture of their “cheers” to the end of malaria, we donate £5 to @MalariaNoMoreUK. Snap your cheers and post it with #MalariaMustDie.— Fever-Tree Mixers (@FeverTreeMixers) April 4, 2018Fever-Tree is donating £5 to Malaria No More UK every time someone posts a picture raising a glass on Instagram or Twitter in April with the hashtag #MalariaMustDie. Warner Edwards’ Honeybee Gin is infused with honey and nectar from its own hives, and has been released in partnership with the Royal Horticultural Society. Each bottle sold supports its work and bottles come with a packet of wildflower seeds so people can plant their own bee-friendly botanicals. Melanie May | 13 April 2018 | News Did you know that Elephant Gin is a foster parent of Mpala & 14 other orphaned elephants saved by @dswt? Their names adorn our miniatures bottles from which 15% of profits go towards @dswt’s orphanage & other conservation activities. Adopt an orphan too at— Elephant Gin (@ElephantGin) February 20, 2018Elephant Gin gives 15% of its proceeds to charities protecting African elephants and other animals in the country. For each full-size bottle sold, 15% of profits are donated to Big Life Foundation and Space for Elephants, while with each miniature bottle, Elephant Gin contributes 15% of profits to The David Sheldrick Wildlife Trust.center_img The One Brand’s One Gin helps fund clean water projects and is available as single bottles, in a case, or in a five litre bag-in-a-box. The One Brand donates its profit to fund life-changing water projects in developing countries and so far has raised over £15 million. Other products include One Water, One Flavoured Water, and One Juiced Water. Tooting’s Graveney Gin Graveney Gin gives 10% of all profits from its handcrafted organic gin to Gearing Up 4 Gorillas, a conservation charity that protects and cares for the rare mountain gorillas in Virunga National Park, Eastern DR Congo. It’s Friday, it’s nearly (ish) gin o’oclock and what better excuse for a glass or two of mother’s ruin this evening than that it’s all in aid of a good cause? Ginerosity is a social enterprise gin, the profits from which help disadvantaged young adults. 8 charity gins & one great tonic The Royal Wootton Bassett Gin Company donates 20% of profits from its Dauntless Gin to military charities Combat Stress, and Cavell Nurses Trust.  574 total views,  2 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis36 AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis36last_img read more

first_img1 de junio. Un levantamiento militante liderado por jóvenes, provocado por el terror policial, se extendió por los Estados Unidos como un incendio forestal y ahora está entrando en su segunda semana. Incluso Trump se declara orgulloso como el presidente de “ley y orden” al amenazar con la presencia de tropas federales en muchas ciudades, y la actual pandemia catastrófica de COVID-19, que resulta en más de 102.000 muertes y aumentos en los Estados Unidos, no ha podido contener este levantamiento provocado por un horrible asesinato policial grabado en video expuesto el 25 de marzo para que todo el mundo lo viera.San Juan, Puerto Rico., 2 de junio.Durante casi nueve minutos, George Floyd, un hombre negro de 46 años, fue torturado y luego linchado por la policía de Minneapolis mientras yacía boca abajo y esposado en la calle. Un oficial de policía presionó su rodilla contra la garganta de Floyd mientras que dos oficiales de lo inmovilizaron sobre su estómago. Antes de que Floyd perdiera el conocimiento por completo, gritaba “No puedo respirar” y llamaba a su difunta madre. Floyd fue inicialmente detenido luego de ser acusado de usar un billete falsificado de $US 20.A pesar de que los agentes de policía, Derek Chauvin, Thomas Lane, J. Alexander Kueng y Tou Thao, fueron despedidos después del incidente, ninguno de ellos fue arrestado de inmediato y acusado de la muerte de Floyd.A John Harrington, comisionado del Departamento de Seguridad Pública de Minnesota, le tomó cuatro días anunciar que Chauvin fue arrestado y acusado de asesinato en tercer grado y homicidio involuntario en segundo grado. Los otros oficiales aún no han sido arrestados ni acusados.La familia Floyd exige que los oficiales Lane, Keung y Thao sean acusados de varios grados de asesinato y Chauvin sea acusado de asesinato en primer grado.Una autopsia independiente realizada el 1 de junio, pagada por la familia Floyd, descubrió que la policía fue responsable de su muerte por “asfixia médica” cuando estuvo privado de oxígeno al cerebro durante casi cinco minutos. Murió en la escena, no en el hospital. Los hallazgos de esta autopsia contradicen los hallazgos iniciales publicados por el médico forense del condado de Hennepin, que afirmó que las condiciones preexistentes causaron la muerte de Floyd, no el homicidio de la policía.El 26 de mayo comenzaron las protestas en Minneapolis y otras ciudades exigiendo justicia para Floyd y arrestos de los oficiales. En un acto audaz el 28 de mayo, los jóvenes incendiaron el tercer cuartel general del departamento de policía de Minneapolis, donde habían trabajado los cuatro oficiales.Docenas de toques de queda declarados en muchas ciudades, respaldados por la presencia de la policía local y estatal y la Guardia Nacional, no han disuadido a los jóvenes de ejercer su derecho a permanecer en las calles para que se escuchen sus voces indignadas, incluso si tenían que hacerlo. tomar arrestos por “desobediencia civil”, si fuera necesario. Miles de personas han sido arrestadas por romper el toque de queda durante seis días de indignación política, expresada por la quema de coches de policía y el cierre de puentes e interestatales.Incluso los periodistas de los principales medios de comunicación como CNN y MSNBC han sido detenidos o golpeados indiscriminadamente con balas de goma y gas pimienta, junto con los manifestantes. Incidentes aislados de jóvenes, incluidos niños, recibieron disparos con pistolas Taser, rociados con pimienta y derribados por la policía antidisturbios fueron captados en video y mostrados en las redes sociales.Los jóvenes manifestantes han utilizado tácticas guerrilleras para evadir a la policía, que está armada hasta los dientes con porras, balas de goma, irritantes químicos e incluso tanques. Los jóvenes solo han tenido rocas, botellas de agua, ladrillos e incluso patinetas para defenderse.La supremacía blanca y la violencia policial vinculadasLos jóvenes están hartos no solo de lo que le sucedió a Floyd, sino también de los asesinatos policiales de Philando Castile, Jamar Clark y otras personas negras en Minnesota.De hecho, este levantamiento, que se ha extendido a al menos 130 ciudades grandes y pequeñas de EE.UU., ha ayudado a exponer los casos de otras personas negras que recientemente perdieron la vida por la violencia policial. Estos incluyen a Breonna Taylor, la trabajadora de EMT de 26 años que fue baleada ocho veces en su cama el 13 de marzo por la policía de Louisville, Kentucky; Tony McDade, un transexual asesinado a tiros el 27 de mayo en Tallahassee, Florida; y David McAtee, un vendedor popular asesinado a tiros hoy, también por la policía de Louisville, solo por nombrar algunos.Las protestas han relacionado estos casos individuales con todas las formas de violencia policial en las comunidades negras y morenas, incluidos los casos desproporcionados de acoso, arrestos y tiroteos. Se presentaron 18 denuncias contra Chauvin por mala conducta; solo se escucharon dos.Muchos de los carteles llevados en las protestas decían: “¡Abolir a la policía!” “¡Todos los policías son malos!” y “¡Todos los policías son bastardos!”El racismo sistémico también ha sido un gran foco de las protestas. Los manifestantes citaron un incidente cuando Christian Cooper, un hombre negro que observaba aves en el Central Park de Nueva York el 25 de mayo, fue abordado por Amy Cooper, una mujer blanca. Llamó al 911 para decirle a la policía que “hay un hombre afroamericano que amenaza mi vida”, lo que lo puso en peligro.Y los manifestantes levantaron el nombre de Ahmaud Arbery, un corredor desarmado que fue asesinado a tiros el 23 de febrero por los supremacistas blancos cerca de Brunswick, Georgia. La policía tardó dos meses en arrestarlos a ellos y a la tercera persona que grabó el video del tiroteo.Los símbolos supremacistas blancos pro-Confederación no han escapado de la ira de los manifestantes, quienes han derrocado o difamado los monumentos de la Confederación en Birmingham, Alabama; Nashville, Tennessee; Richmond, Virginia; y Charleston, Carolina del Sur, se incendiaron las United Daughters of the Confederacy Memorial Building en Richmond y Market House, el sitio de una subasta de esclavos en Fayetteville, Carolina del Norte.Defensa global de la solidaridadTrump ha sido llamado el “supremacista blanco número uno”, y con razón. Sus tweets se han referido a los manifestantes con la connotación racista de “matones”. Él ha declarado que cuando comienza el “saqueo”, comienza el “tiroteo”. Ha declarado que el movimiento “antifa” (también conocido como antifascistas) es una organización “terrorista”, y ha llamado a los gobernadores “imbéciles” si no “dominan” y arrestan a los manifestantes.Por su sola presencia, es la policía la que incita a la violencia, no los manifestantes.Trump hizo una amenaza para llamar a su base neofascista para enfrentar a los manifestantes antes de dar marcha atrás en esa amenaza. Miles de manifestantes se enfrentaron a los agentes del Servicio Secreto y a la policía local en el Parque Lafayette en Washington, D.C., frente a la Casa Blanca el 1 de junio. Durante varias noches, los fuegos artificiales explotaron lo suficientemente fuerte como para que los escuchasen en la Casa Blanca.No se sabe cuánto durará este levantamiento, ya sean días o semanas o más. Hay un absoluto: esta rebelión no tiene precedentes por estar compuesta predominantemente de jóvenes, sino que es multinacional con manifestantes negros, latinx, indígenas, asiáticos y blancos que se unen. Se niegan a guardar silencio cuando se trata de ser solidarios con el movimiento Black Lives Matter y de condenar todas las formas de violencia policial.Este levantamiento, al igual que la pandemia, ha impactado a todos los sectores de la sociedad estadounidense.Destacadas figuras del deporte aficionado y profesional se han pronunciado contra el racismo y, en algunos casos, asistieron a manifestaciones junto con artistas.Los manifestantes se han arrodillado en las calles en solidaridad con el ex mariscal de campo de la Liga Nacional de Fútbol americano, Colin Kaepernick, quien se arrodilló por primera vez en 2016 en oposición a la brutalidad policial.Este levantamiento también ha tenido un efecto dominó en todo el mundo, con acciones de solidaridad en ciudades de África y Medio Oriente, Australia, Bélgica, Brasil, Gran Bretaña, Alemania, Irán, Irlanda, Italia, Nueva Zelanda y otros lugares.Los políticos liberales burgueses y reaccionarios y sus voceros de los medios de comunicación intentan abrir una brecha entre los participantes en el levantamiento, etiquetando a muchos manifestantes negros como “pacíficos” y muchos manifestantes blancos “anarquistas”.Estos apologistas de la clase dominante temen cuán lejos y cuán profunda podría llegar esta rebelión para romper el frágil sistema capitalista, que ya se está recuperando de la pandemia de coronavirus y la crisis económica en curso.¡Esta rebelión necesita solidaridad política, no aislamiento! Esa es razón suficiente para exigir: ¡Ningún estado policial! ¡Sin dictadura militar! ¡Amnistía para todos los arrestados! ¡Retirar a la policía y la Guardia Nacional! y ¡Sin justicia, no hay paz!FacebookTwitterWhatsAppEmailPrintMoreShare thisFacebookTwitterWhatsAppEmailPrintMoreShare thislast_img read more

first_img WhatsApp Pinterest Facebook Twitter Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results Pinterest By Digital AIM Web Support – February 23, 2021 WhatsAppcenter_img Facebook SAN DIEGO, Feb. 23, 2021 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on its recent corporate activities and outlook. “The fourth quarter capped an extraordinary year for Halozyme during which we transitioned to a profitable, high-growth company with strong prospects for continued growth over the long-term,” said Dr. Helen Torley, president and chief executive officer. “Our strong growth prospects are fueled by recent product approvals for subcutaneous DARZALEX® (daratumumab) and Phesgo® (pertuzumab, trastuzumab and hyaluronidase) utilizing our ENHANZE® technology. Building on our portfolio of 5 commercialized partner products, we project the expansion of our development pipeline, including 4 products being evaluated in 7 phase 3 studies utilizing our ENHANZE® technology. We believe this advancing pipeline of products utilizing our ENHANZE® technology is setting the potential for multiple waves of future product launches that will deliver long-term growth in revenues, profitability and cash flow.” Fourth Quarter 2020 and Recent Highlights Include: In February 2021, argenx announced a “go” decision for its ADHERE trial evaluating subcutaneous (SC) efgartigimod with ENHANZE® technology in chronic inflammatory demyelinating polyneuropathy (CIDP). argenx plans to continue enrollment to include approximately 130 patients to support potential registration of SC efgartigimod for the treatment of CIDP.In January 2021, ENHANZE® partner Janssen Biotech, Inc. (Janssen) received U.S. Food and Drug Administration (FDA) accelerated approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis. AL amyloidosis is a rare and potentially fatal disease that develops when plasma cells in the bone marrow generate abnormal light chains, which form amyloid deposits in vital organs and lead to organ deterioration. There were previously no approved therapies for the disease.In January 2021, argenx initiated a Phase 3 study of ARGX-113 with ENHANZE® technology in pemphigus vulgaris and pemphigus foliaceus, rare autoimmune diseases that cause painful blisters on the skin and mucous membranes.In December 2020, argenx initiated a Phase 3 study of ARGX-113 with ENHANZE® technology for patients with immune thrombocytopenia (ITP), an immune disorder in which the blood does not clot normally, resulting in a $15 million payment to Halozyme.In December 2020, Roche initiated a Phase 3 study in patients with non-small cell lung cancer for Tecentriq® (atezolizumab) with ENHANZE® technology, resulting in a $17 million payment to Halozyme.In December 2020, the Company announced that the European Commission approved Roche’s Phesgo®, a fixed-dose combination of Perjeta® (pertuzumab) and Herceptin® (trastuzumab) with ENHANZE® technology, administered by SC injection for the treatment of patients with early and metastatic HER2-positive breast cancer. This was the first time the European Commission approved a product combining two monoclonal antibodies that can be administered by a single SC injection utilizing ENHANZE® technology.In November 2020, the Company announced a global collaboration and license agreement that provides Horizon Therapeutics plc exclusive access to ENHANZE® technology for SC formulation of medicines targeting IGF-1R for which the Company received an upfront payment of $30 million. Horizon intends to use ENHANZE® technology to develop a SC formulation of TEPEZZA® (teprotumumab-trbw), indicated for the treatment of Thyroid Eye Disease, a serious, progressive and vision-threatening rare autoimmune disease, potentially shortening drug administration time, reducing healthcare practitioner time and offering additional flexibility and convenience for patients.In November 2020, Janssen initiated a Phase 1 study of amivantamab utilizing ENHANZE® technology in advanced solid tumors.In November 2020, the Company announced that Janssen submitted regulatory applications to the FDA and European Medicines Agency (EMA) seeking approval of DARZALEX FASPRO® in the U.S. and as DARZALEX® SC in the European Union (EU) utilizing ENHANZE® technology in combination with pomalidomide and dexamethasone (D-Pd) for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy.In November 2020, Janssen submitted a Type II variation application to the EMA seeking European approval for DARZALEX® SC utilizing ENHANZE® technology to be used in the treatment of patients with AL amyloidosis.In October 2020, the Company announced that argenx expanded its existing global collaboration and license agreement that was signed in February 2019. Under the expansion, argenx gained the ability to exclusively access Halozyme’s ENHANZE® drug delivery technology for three additional targets upon nomination for a total of up to six targets. To date, argenx has nominated two targets including the human neonatal Fc receptor FcRn, which is blocked by efgartigimod, and complement component C2.During the fourth quarter, the Company repurchased approximately 1.1 million shares of common stock for $37.6 million at an average price per share of $34.36, bringing the total 2020 repurchases to $150.0 million at an average price of $23.05. Fourth Quarter and Full Year 2020 Financial Highlights Revenue for the fourth quarter was $121.7 million compared to $53.7 million for the fourth quarter of 2019. The year-over-year increase was primarily driven by a $30.0 million upfront payment from Horizon, a $15.0 million sales milestone from Janssen, an increase in royalty revenue following the strong DARZALEX FASPRO® launch during the second quarter and an increase in product sales. Revenue for the quarter included $32.0 million in royalties, an increase of 86% compared to $17.2 million in the prior year period. Total revenues for the full year were $267.6 million, compared with $196.0 million in 2019, representing growth of 37% year over year.Research and development expenses for the fourth quarter were $7.4 million, compared to $45.1 million for the fourth quarter of 2019. The decrease in expenses was due to a decrease in clinical trial activities-related costs as a result of the Company halting its oncology drug development efforts beginning in November 2019 and one-time restructuring charges of $17.2 million in the prior year related to the shift in strategic focus to the Company’s ENHANZE® technology. Research and development expenses for the full year were $34.2 million, compared with $140.8 million in 2019.Selling, general and administrative expenses for the fourth quarter were $10.4 million, compared to $23.9 million for the fourth quarter of 2019. The decrease was due to lower compensation and commercial-related expenses related to the corporate restructuring announced in November 2019 and a one-time restructuring charge of $11.2 million in the prior year. Selling, general and administrative expenses for the full year were $45.7 million, compared with $77.3 million in 2019.Operating income for the fourth quarter was $77.6 million, compared to an operating loss of $32.1 million in the fourth quarter of 2019. Operating income for the full year was $144.3 million, compared to an operating loss of $67.6 million in 2019.Net income for the fourth quarter was $73.2 million, or $0.50 per share, compared to a net loss in the fourth quarter of 2019 of $34.4 million, or loss of $0.24 per share. Net income for the full year was $129.1 million or $0.91 per share, compared to a net loss of $72.2 million or loss of $0.50 per share in 2019.Cash, cash equivalents and marketable securities were $368.0 million at December 31, 2020, compared to $421.3 million at December 31, 2019.During 2020, the Company repurchased 6.5 million shares of common stock for $150 million at an average price of $23.05, bringing the total for share repurchases since the announcement of the Company’s three-year share repurchase program to $350.0 million at an average price of $19.88. Financial Outlook for 2021 Based on the latest information from collaboration partners and planned expenditures for the year, the Company expects: Revenues of $375 million to $395 million, representing year-over-year growth of 40%-48%, with revenues from royalties projected to approximately double versus 2020;Operating Income of $215 million to $235 million, representing year-over-year growth of 49%-63%;Earnings per share on a GAAP basis of $1.40 to $1.55, representing year-over-year growth of 54%-70%. The Company plans to repurchase up to $125 million in common stock during 2021 as part of the $550 million three-year share repurchase plan authorized by Halozyme’s board of directors in 2019. The amount and timing of shares to be repurchased in 2021 will be subject to a variety of factors including market conditions, other business considerations and applicable legal requirements. Webcast and Conference Call Halozyme will webcast its Quarterly Update Conference Call for the fourth quarter of 2020 today, Tuesday, February 23, 2021 at 4:30 p.m. ET/1:30 p.m. PT. Dr. Torley will lead the call, which will be webcast live through the “Investors” section of Halozyme’s corporate website and a replay will be available following the close of the call. To register for this conference call, please use this link: After registering, you will receive an email confirmation that includes dial in details and unique conference call codes for entry. Registration is open through the live call. However, to ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. About Halozyme Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. Halozyme advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients’ lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE® technology, which can reduce hours-long treatments to a matter of minutes, Halozyme’s commercially-validated solution has positively impacted more than 400,000 patient lives via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs intended to deliver innovative therapies, with the potential to improve the lives of patients around the globe. Halozyme’s proprietary enzyme rHuPH20 forms the basis of the ENHANZE® technology and is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs to patients. Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Baxalta, Pfizer, Janssen, AbbVie, Lilly, Bristol-Myers Squibb, Alexion, argenx and Horizon Therapeutics. Halozyme derives revenues from these collaborations in the form of milestones and royalties as the Company’s partners make progress developing and commercializing their products being developed with ENHANZE®. Halozyme is headquartered in San Diego. For more information visit Safe Harbor Statement In addition to historical information, the statements set forth in this press release include forward-looking statements including, without limitation, statements concerning the Company’s expected future financial performance (including the Company’s financial outlook for 2021) and expectations for future growth, profitability, revenue, operating income, cash flow, expenses and earnings-per-share and the Company’s plans to continue its share repurchase program. Forward-looking statements regarding the Company’s ENHANZE® drug delivery technology may include the possible activity, benefits and attributes of ENHANZE®, the possible method of action of ENHANZE®, its potential application to aid in the dispersion and absorption of other injected therapeutic drugs and facilitating more rapid delivery of injectable medications through subcutaneous delivery. Forward-looking statements regarding the Company’s ENHANZE® business may include potential growth driven by our partners’ development and commercialization efforts, the size and growth prospects of our partners’ drug franchises, potential new ENHANZE® collaborations and collaborative targets and regulatory review and potential approvals of new ENHANZE® products. These forward-looking statements are typically, but not always, identified through use of the words “believe,” “enable,” “may,” “will,” “could,” “intends,” “estimate,” “anticipate,” “plan,” “predict,” “probable,” “potential,” “possible,” “should,” “continue,” and other words of similar meaning and involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Actual results could differ materially from the expectations contained in these forward-looking statements as a result of several factors, including unexpected levels of revenues, expenditures and costs, inability to sustain profitability, unexpected delays in the execution of the Company’s share repurchase program, unexpected results or delays in the growth of the Company’s ENHANZE® business, or in the development, regulatory review or commercialization of ENHANZE® products, including any potential delays caused by the current COVID-19 global pandemic, regulatory approval requirements, unexpected adverse events or patient outcomes and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company’s most recently filed Annual Report on Form 10-K filed with the Securities and Exchange Commission. Contact: Al Kildani Vice President, Investor Relations and Corporate Communications 858-704-8122 [email protected] View original content to download multimedia: SOURCE Halozyme Therapeutics, Inc. Previous articleIndian Country gripped by Haaland hearing for top US postNext articleSquare, Inc. Announces Fourth Quarter and Full Year 2020 Results Digital AIM Web Support TAGS  Twitter Local NewsBusinesslast_img read more

first_img Demand Propels Home Prices Upward 2 days ago Related Articles Governmental Measures Target Expanded Access to Affordable Housing 2 days ago Previous: NMSA and HUD Work to Improve CWCOT Program Next: How Many Americans Cite Housing as Primary Debt Driver? The Week Ahead: Nearing the Forbearance Exit 2 days ago A Look Back at Real Estate Performance Subscribe The Best Markets For Residential Property Investors 2 days ago Applications mortgage 2020-02-26 Seth Welborn  Print This Post About Author: Seth Welborn in Daily Dose, Featured, Market Studies, News Home / Daily Dose / A Look Back at Real Estate Performance Demand Propels Home Prices Upward 2 days agocenter_img Data Provider Black Knight to Acquire Top of Mind 2 days ago Share Save Governmental Measures Target Expanded Access to Affordable Housing 2 days ago Data Provider Black Knight to Acquire Top of Mind 2 days ago February 26, 2020 1,213 Views Tagged with: Applications mortgage Servicers Navigate the Post-Pandemic World 2 days ago From rent and home price appreciation to loan performance and the end of LIBOR, CoreLogic’s latest Market Pulse report reviews the most important data for servicers and lenders alike. According to the report, U.S. single-family rents increased 2.9% year over year in December 2019, while the national CoreLogic Home Price Index increased more than 3% in 2019 and is forecast to rise about 5% in 2020.CoreLogic found that the nation’s overall delinquency was 3.9% in November 2019, which is a marginal decline from last year’s 4%. November’s reading was the lowest reading for November in more than 20 years.The share of delinquent mortgages in November historically peaked in 2009 at 11.5%. Since March 2018, the overall delinquency rate each month has been lower than the pre-crisis period from 2000 to 2006. The rate averaged 4.7% during that time.The report also covered the end of LIBOR. Jacqueline Doty, Executive, Product Management, Collateral Risk Solutions at CoreLogic, explained that the end of LIBOR will impact $1.2 trillion dollars in adjustable-rate mortgages.”It means that lenders with loans or lines of credit based on the LIBOR index will need to identify and review the terms of all of their LIBOR loans,” said Doty. “A portfolio of loans likely contains a wide variety of terms regarding LIBOR, and this will need to be assessed.”LIBOR’s end is likely to impact more than lenders and borrowers. According to Fitch Ratings, U.S. RMBS servicers showed an improved awareness of difficulties and implications tied to the anticipated expiration of LIBOR at the end of 2021.To help facilitate the likely transition away from LIBOR, Doty notes that the Federal Reserve convened a working group called the Alternative Reference Rates Committee. The ARRC has recommended an alternative to the LIBOR index called the Secured Overnight Financing Rate (SOFR) and has started promoting its use on a voluntary basis.Lenders may need to face modification. Between now and the end of LIBOR, there’s a good possibility that many loans will need to be modified because the fallback provisions are either nonexistent, unclear or impractical.”For example, in some cases, the margin cannot be adjusted and it is either too high or too low when added to the new alternate index,” Doty said.But there’s no need to panic just yet,” she adds. “The good news is there’s still time to successfully manage a smooth and efficient transition. Now is a good time for lenders to start auditing their loan data and documents and planning for fulfillment of amendments or borrower notifications.” Servicers Navigate the Post-Pandemic World 2 days ago Seth Welborn is a Reporter for DS News and MReport. A graduate of Harding University, he has covered numerous topics across the real estate and default servicing industries. Additionally, he has written B2B marketing copy for Dallas-based companies such as AT&T. An East Texas Native, he also works part-time as a photographer. Sign up for DS News Daily The Best Markets For Residential Property Investors 2 days agolast_img read more

first_imgColumnsBurial Or Cremation : Right To Dignity Of The Dead Amid COVID-19 Sparsh Upadhyay22 April 2020 12:26 AMShare This – xIn William Shakespeare’s celebrated work ‘Hamlet’, there is a scene, where Gertrude (The Queen of Denmark), in a failed attempt to console her son, Hamlet, (who has just lost his father) and to persuade him to move beyond his mourning period, unusually says, “All that lives must die, passing through nature to eternity.” Even though Hamlet isn’t very moved (quite obviously) and impressed with…Your free access to Live Law has expiredTo read the article, get a premium account.Your Subscription Supports Independent JournalismSubscription starts from ₹ 599+GST (For 6 Months)View PlansPremium account gives you:Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.Subscribe NowAlready a subscriber?LoginIn William Shakespeare’s celebrated work ‘Hamlet’, there is a scene, where Gertrude (The Queen of Denmark), in a failed attempt to console her son, Hamlet, (who has just lost his father) and to persuade him to move beyond his mourning period, unusually says, “All that lives must die, passing through nature to eternity.” Even though Hamlet isn’t very moved (quite obviously) and impressed with her argumentation and philosophy, but we, the readers of the Shakespearean tragedy know it well that through Gertrude, Shakespeare is giving all of us a rude reminder – the fact, that death is indeed inevitable. While death is considered to be a natural phenomenon, the basic decent treatment which is expected and ought to be given to the dead doesn’t always germinate and actualise naturally. And recently, we had to witness such an unfortunate case, where the burial of a Doctor, Dr Simon Hercules, who succumbed to a heart attack (his on-going health problems having been aggravated on account of COVID infection) invited mass opposition, creating a law and order situation in Chennai. Not just that, the mob even pelted stones and attacked the ambulance (twice) in which the dead body of Dr Simon Hercules was being taken to the burial ground. The situation had turned so violent they the colleagues of Dr Simon carrying his mortal remains had to flee to save themselves from the mob; later they had to dig a grave with bare hands to bury his dead body. Soon thereafter the Madras High Court had to step in to issue a notice to the state on its motion to remind that the scope and ambit of Article 21 includes, right to have a decent burial. The Division Bench of the High Court had to make the categorical remark that, “In the considered opinion of the Court the scope and ambit of Article 21 includes, right to have a decent burial. It prima facie appears that as a consequence of above said alleged acts, a person who practiced a noble profession as a doctor and breathed his last, has been deprived of his right, to have a burial, in a cemetery earmarked for that purpose and that apart, on account of law and order and public order problem created, the officials who have performed their duties, appeared have sustained grievous injuries.” This heart-rending incident from Chennai reminds me of Bahadur Shah Zafar, the last Mughal emperor and his poetic lament. Unable to find a final resting place in his beloved homeland (India), the last Mughal emperor quite rightly summarised the plight of the dead – Kitna hai badnaseeb Zafar dafn ke liye/Do gaz zameen bhi na mili koo-e-yaar mein (How unlucky is Zafar! For burial, even two yards of land were not to be had in the land of his beloved). In the immediate past, just like the ‘Novel’ CoronaVirus, a ‘Novel’ dilemma too, has come up for our consideration, and which would ultimately form the bedrock of the present article, which is – once a COVID-19 infected person dies, should we be burying him/her or cremating him/her? What are the current Guidelines on this point? And last but not the least; do we owe a duty to hand out a decent burial/cremation to a COVID-19 infected patient? To arrive at a categorical conclusion, we would glance through the Guidelines issued by the Ministry of Health & Family Welfare, Government of India, some recent controversies and some celebrated case laws, to put things into perspective. Ministry of Health & Family Welfare Guidelines On 15th of March 2020, Directorate General of Health Services (EMR Division), Ministry of Health & Family Welfare, Government of India released a document containing ‘Guidelines On Dead Body Management (COVID-19)’ – [hereinafter, ‘Document’]. Till date, it remains un-amended and it is based on the Ministry’s current epidemiological knowledge about the COVID-19. The Document acknowledges the fact that “since India is currently having travel-related cases and few cases of local transmission” only and so it is but natural that “at this stage, all suspect/ confirmed cases (of COVID-19) will be isolated in a health care facility.” Hence the Document is limited in scope to hospital deaths only. What all is allowed at the Crematorium/Burial Ground? (Point No. 11 of the Document) In this section, we would be looking at the bare guidelines issued by the Ministry of Health & Family Welfare, Government of India in the concerned document. The Crematorium/ burial Ground staff should be sensitized that COVID-19 does not pose additional risk. The staff will practice standard precautions of hand hygiene, use of masks and gloves.Viewing of the dead body by unzipping the face end of the body bag (by the staff using standard precautions) may be allowed, for the relatives to see the body for one last time.Religious rituals such as reading from religious scripts, sprinkling holy water and any other last rites that does not require touching of the body can be allowed. Bathing, kissing, hugging, etc. of the dead body should not be allowed.The funeral/ burial staff and family members should perform hand hygiene after cremation/ burial.The ash does not pose any risk and can be collected to perform the last rites.Large gathering at the crematorium/ burial ground should be avoided as a social distancing measure as it is possible that close family contacts may be symptomatic and/ or shedding the virus. It is important to note that none of the above-mentioned 7 points (forming part of the Guidelines) disallows the Cremation or Burial to take place of bodies of COVID-19 victims. Also, even the family members of COVID-19 victims are not prevented from attending and performing the last rites (according to their own religious beliefs) of their kin. However, many states have restricted the number of people who could be present at the burial/cremation place, while the last rites are being performed. While the Guidelines are unambiguous, there have been many controversies around the mode of disposal of bodies of COVID-19 victims and they have created unnecessary panic among the people (among both, religious minorities and family members of COVID-19 victims). Before moving on to the unsettled and much graver issues, let’s just quickly cast our eyes over two such controversies, one from the United Kingdom and another from Maharashtra which created much uproar but were settled quite promptly and harmoniously. The United Kingdom’s Controversial Bill With the surge of COVID-19 Patients, the UK Government sought to bring in emergency legislation – ‘The Coronavirus Act 2020’, which contained a provision under which, designated local authorities could disregard section 46(3) of the Public Health (Control of Disease) Act 1984, which is primarily aimed to prevent a local authority from being able to cremate a body against the wishes of the deceased overriding his/her religious beliefs. In other words, a provision of the said bill (now an Act minus this particular provision) sought to impose compulsory cremation on coronavirus victims. Apart from other controversial elements of the initial proposal, there was a section in the proposed bill, which would have given local authorities the power to cremate (actually forcefully cremate) the bodies of COVID-19 victims (discarding his/her religious beliefs) without his/her (or family’s) consent. However, after receiving complaints and strong objections from religious minorities (Jews and Muslims) of the country that it would infringe on their burial rights, the UK government later changed its mind. An amendment was later incorporated in the bill (now an Act), which stated that the authorities must “have regard” for the disposal of bodies “in accordance with the person’s wishes, if known, or otherwise in a way that appears consistent with the person’s religion or beliefs, if known.” It is crucial to note that on 12th of April, Sri Lanka had made cremations compulsory for COVID-19 victims irrespective of their religion. Apart from the country’s Muslim population, this decision has also been criticised by rights groups of the country. Maharashtra’s Civic Body Circular On March 30th, 2020 (7 days after the United Kingdom had settled the Cremation-Burial Controversy), Maharashtra Civic Body, The Brihanmumbai Corporation (BMC), deriving powers conferred under sections 2, 3 and 4 of Epidemic Diseases Act, 1897, notified the circular that all bodies of COVID-19 victims shall be cremated “at the nearest crematorium irrespective of their religion.” Soon thereafter, Cabinet minister in Maharashtra Government and NCP MLA, Nawab Malik intervened in this matter, and as a result of this, the circular was hurriedly withdrawn and the civic body came up with a revised circular (now in force), which states that burials will be permitted if there is an availability of a big burial site. It also clarifies that the burial should take place in a deep grave. The Bombay HC also observed that the revised circular does not prevent burial of COVID-19 infected persons. However, it has also been notified in the revised circular that if someone in-fact wants to bury the body of the deceased, the kin and other family members have to make sure that necessary precautions are taken care of (zero possibility of transmission/spread of virus) and burial proceedings/practices shall take place in the presence of police. However, on the 1st of April, just one day after the controversial circular was amended by BMC, a Muslim man who died from COVID-19 infection, could not get a place for burial in Mumbai, and so the local administration had to take the dead body to the nearest Hindu cemetery ground, where it was cremated with all honours. Rights of the Dead and Indian Courts The Supreme Court of India along with many High Courts has, through many celebrated Judgments accepted that the human corpse (dead body) should be treated with appropriate dignity and it should be given fair treatment. In Pt. Parmanand Katara v. Union of India & Anr. (1995) 3 SCC 248, the Supreme Court dealt with a contention, wherein it was urged that the method of execution of death sentence by hanging under Punjab Jail Manual is inhumane and is violative of Article 21 of the Constitution (the Court, later on, rejected this very contention). It was further argued that the requirement in the said Jail Manual, that the body of the hanged convict after it falls from the scaffolds is required to be suspended for a period of half an hour (even after the medical officer has declared the person to be dead), is violative of Article 21 since even a dead person has a right to dignity and fair treatment in respect of his dead body. The Supreme Court therein upheld the said contention of the petitioner and held that the right to dignity and fair treatment under Article 21 of the Constitution is not only available to a living man, but also to his body after his death. The Supreme Court went on to state that the Jail authorities shall not keep the body of any condemned prisoner suspended after the medical officer has declared the person to be dead. Not just that, if we talk about the religious practices of disposing of a dead body, the courts have also taken due care in upholding such religious rights of families of people who have died. It is to be kept in mind, and as we have observed, that the Document containing Guidelines issued by the Ministry of Health & Family Welfare, Government of India on 15th March 2020, does take into consideration, the religious rights of families of people who have died. Further, in the case of Vareed Porinchukutty v. State of Kerala and Ors. 1971 KLT 204, it was held that practices which are regarded by the community as part of its religion are also matters of religion. In this case (Vareed Porinchukutty), it was held that the different modes of disposing of bodies (in different religions) are an integral part of their faith and while exercising this right, they only exercise their fundamental right under Article 25 of the Constitution of India regarding the practice of their religion. The relevant paragraph from the Judgment reads: “22. Practices which are regarded by the community as part of its religion are also matters of religion. Among most of the Hindus disposal of the dead is effected by cremation but among Muslims, Jews and Christians it is done by burial. Right to bury dead bodies in a particular manner with particular rites and ceremonies in consecrated places is part and parcel of the practice of certain religions. Among Christians while rites at the time of burial consist in services expressed in words ceremonies consist in gestures or acts preceding, accompanying or following those words. Catholics, it is admitted that members of a party are Catholics, believe in the immortality of the soul and resurrection of the body. The practice of burying dead bodies with certain rites and ceremonies is an integral part of the Catholic faith. In burying dead bodies in consecrated places they only exercise their fundamental right regarding practice of religion.” In one of the Guidelines issued by the Ministry of Health & Family Welfare, it has been mentioned that religious rituals (minus actually touching the body) should be allowed. In fact, that particular guideline is an attempt to take into consideration, the religious practices of people belonging to difference sects/religions. Not just religious practices, but Right to decent burial has also been recognised by the Indian Courts. In fact, in the year 2007, the Madras high court in the case of S.Sethu Raja vs The Chief Secretary (2007) 5 MLJ 404 had held in para 18 of the Judgment that by our tradition and culture, the same human dignity (if not more) with which a living human being is expected to be treated, should also be extended to a person who is dead and the right to accord a decent burial or cremation to the dead body of a person should be taken to be a part of the right to such human dignity. Again, in Marimuthu vs State Criminal Appeal Nos.618/1995 and 620/1995, the Madras high court had observed that “Every human being is entitled to a decent disposal of his body after his death in accordance with his culture and tradition.” Burial versus Cremation: The Unnecessary Debate? Dr Sailo, a 69-year-old doctor, the first coronavirus fatality in Meghalaya, passed away on 15th April. A tribal body in the state disallowed his burial after residents of Jhalupara in Meghalaya capital Shillong earlier stopped the cremation of the dead body to take place. This all happened because they feared that the virus would spread from the dead body. A Public Interest Litigation was filed by the High Court of Meghalaya Bar Association in the Meghalaya High Court and on 16th April the Court took serious note of the obstruction caused to the funeral. The Court observed that this incident which happened on April 15 “shocked the conscience of every right-thinking individual”. There have been many reported instances where local residents have created obstruction in the burial/cremation of COVID-19 infected patients. On 2nd of April, a day after he tested positive of Coronavirus, Padma Shri awardee Bhai Nirmal Singh Khalsa passed away. The residents of Verka village in Amritsar district refused the body to be cremated. However, later on, the villagers provided separate land for final rites and the controversy was put to rest. Sudhir Gupta, head of the forensic medicine department of the AIIMS, New Delhi, has been quoted as saying by news agency Press Trust Of India, that “Cremation of a person who has died due to coronavirus poses no threat through any methods — using fire or electrical, gas or by burial.” On 24th of March 2020, when the World Health Organization issued a Document containing similar guidelines, it has also made it clear that people who have died from COVID-19 could either be buried or cremated. The document issued by it also mentions that the body of a COVID-19 victim is “generally not infectious”. It could be argued and as many doctors have also suggested, that the body of a COVID-19 victim remains contaminated even after his/her death, as the virus is still in the body. And so, the people who are handling the bodies for the last rites (including the medical team, religious persons and family members) could be said to be vulnerable. However, it is altogether a different matter from whether we should actually allow the family members to choose the way in which they wish to dispose of the dead body of their loved ones. In fact, through guidelines and allied laws, we can restrict the number of people who could be allowed to attend the body of a COVID-19 victim and many state Governments have done just that. In the end, it is important to reiterate that while the Guidelines issued by World Health Organisation & Ministry of Health & Family Welfare are quite clear about the fact that the body of a COVID-19 victim could be disposed of in any manner, the unnecessary controversies related to it does no good to the people who are already facing several problems across the globe and most importantly in India.  Subscribe to LiveLaw, enjoy Ad free version and other unlimited features, just INR 599 Click here to Subscribe. All payment options available.loading….Next Storylast_img read more